91 related articles for article (PubMed ID: 27573869)
1. Genome-wide profiling of chemoradiation‑induced changes in alternative splicing in colon cancer cells.
Xiong W; Gao D; Li Y; Liu X; Dai P; Qin J; Wang G; Li K; Bai H; Li W
Oncol Rep; 2016 Oct; 36(4):2142-50. PubMed ID: 27573869
[TBL] [Abstract][Full Text] [Related]
2. The early response to DNA damage can lead to activation of alternative splicing activity resulting in CD44 splice pattern changes.
Filippov V; Filippova M; Duerksen-Hughes PJ
Cancer Res; 2007 Aug; 67(16):7621-30. PubMed ID: 17699766
[TBL] [Abstract][Full Text] [Related]
3. Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis.
Thorsen K; Sørensen KD; Brems-Eskildsen AS; Modin C; Gaustadnes M; Hein AM; Kruhøffer M; Laurberg S; Borre M; Wang K; Brunak S; Krainer AR; Tørring N; Dyrskjøt L; Andersen CL; Orntoft TF
Mol Cell Proteomics; 2008 Jul; 7(7):1214-24. PubMed ID: 18353764
[TBL] [Abstract][Full Text] [Related]
4. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array.
Gardina PJ; Clark TA; Shimada B; Staples MK; Yang Q; Veitch J; Schweitzer A; Awad T; Sugnet C; Dee S; Davies C; Williams A; Turpaz Y
BMC Genomics; 2006 Dec; 7():325. PubMed ID: 17192196
[TBL] [Abstract][Full Text] [Related]
5. Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancer.
de Miguel FJ; Sharma RD; Pajares MJ; Montuenga LM; Rubio A; Pio R
Cancer Res; 2014 Feb; 74(4):1105-15. PubMed ID: 24371231
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of serine/arginine-rich splicing factor 3 induces G1 cell cycle arrest and apoptosis in colon cancer cells.
Kurokawa K; Akaike Y; Masuda K; Kuwano Y; Nishida K; Yamagishi N; Kajita K; Tanahashi T; Rokutan K
Oncogene; 2014 Mar; 33(11):1407-17. PubMed ID: 23503458
[TBL] [Abstract][Full Text] [Related]
7. MSH3 expression does not influence the sensitivity of colon cancer HCT116 cell line to oxaliplatin and poly(ADP-ribose) polymerase (PARP) inhibitor as monotherapy or in combination.
Tentori L; Muzi A; Dorio AS; Dolci S; Campolo F; Vernole P; Lacal PM; Praz F; Graziani G
Cancer Chemother Pharmacol; 2013 Jul; 72(1):117-25. PubMed ID: 23636450
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide analysis of novel splice variants induced by topoisomerase I poisoning shows preferential occurrence in genes encoding splicing factors.
Solier S; Barb J; Zeeberg BR; Varma S; Ryan MC; Kohn KW; Weinstein JN; Munson PJ; Pommier Y
Cancer Res; 2010 Oct; 70(20):8055-65. PubMed ID: 20817775
[TBL] [Abstract][Full Text] [Related]
9. Comparison of gene expression in HCT116 treatment derivatives generated by two different 5-fluorouracil exposure protocols.
De Angelis PM; Kravik KL; Tunheim SH; Haug T; Reichelt WH
Mol Cancer; 2004 Apr; 3():11. PubMed ID: 15109396
[TBL] [Abstract][Full Text] [Related]
10. Acquired resistance to 5-fluorouracil via HSP90/Src-mediated increase in thymidylate synthase expression in colon cancer.
Ahn JY; Lee JS; Min HY; Lee HY
Oncotarget; 2015 Oct; 6(32):32622-33. PubMed ID: 26416450
[TBL] [Abstract][Full Text] [Related]
11. Identification of radiation-induced aberrant hypomethylation in colon cancer.
Bae JH; Kim JG; Heo K; Yang K; Kim TO; Yi JM
BMC Genomics; 2015 Feb; 16(1):56. PubMed ID: 25887185
[TBL] [Abstract][Full Text] [Related]
12. AURKA Increase the Chemosensitivity of Colon Cancer Cells to Oxaliplatin by Inhibiting the TP53-Mediated DNA Damage Response Genes.
Shan B; Zhao R; Zhou J; Zhang M; Qi X; Wang T; Gong J; Wu Y; Zhu Y; Yang W; Zhang Y; Wang G; Li X
Biomed Res Int; 2020; 2020():8916729. PubMed ID: 32851091
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
[TBL] [Abstract][Full Text] [Related]
14. A statistical framework for genome-wide discovery of biomarker splice variations with GeneChip Human Exon 1.0 ST Arrays.
Yoshida R; Numata K; Imoto S; Nagasaki M; Doi A; Ueno K; Miyano S
Genome Inform; 2006; 17(1):88-99. PubMed ID: 17503359
[TBL] [Abstract][Full Text] [Related]
15. Alternative Splicing, DNA Damage and Modulating Drugs in Radiation Therapy for Cancer.
Tang JY; Li RN; Chen PH; Huang HW; Hou MF; Chang HW
Anticancer Agents Med Chem; 2015; 15(6):674-80. PubMed ID: 25902333
[TBL] [Abstract][Full Text] [Related]
16. Purvalanol induces endoplasmic reticulum stress-mediated apoptosis and autophagy in a time-dependent manner in HCT116 colon cancer cells.
Coker-Gürkan A; Arisan ED; Obakan P; Akalın K; Özbey U; Palavan-Unsal N
Oncol Rep; 2015 Jun; 33(6):2761-70. PubMed ID: 25901510
[TBL] [Abstract][Full Text] [Related]
17. Influence of MLH1 on colon cancer sensitivity to poly(ADP-ribose) polymerase inhibitor combined with irinotecan.
Tentori L; Leonetti C; Muzi A; Dorio AS; Porru M; Dolci S; Campolo F; Vernole P; Lacal PM; Praz F; Graziani G
Int J Oncol; 2013 Jul; 43(1):210-8. PubMed ID: 23653048
[TBL] [Abstract][Full Text] [Related]
18. Characterization of side population cells isolated from the colon cancer cell line SW480.
Xiong B; Ma L; Hu X; Zhang C; Cheng Y
Int J Oncol; 2014 Sep; 45(3):1175-83. PubMed ID: 24926880
[TBL] [Abstract][Full Text] [Related]
19. Integrated omics profiling identifies hypoxia-regulated genes in HCT116 colon cancer cells.
Chen JT; Liu CC; Yu JS; Li HH; Lai MC
J Proteomics; 2018 Sep; 188():139-151. PubMed ID: 29524648
[TBL] [Abstract][Full Text] [Related]
20. Radiation and SN38 treatments modulate the expression of microRNAs, cytokines and chemokines in colon cancer cells in a p53-directed manner.
Pathak S; Meng WJ; Nandy SK; Ping J; Bisgin A; Helmfors L; Waldmann P; Sun XF
Oncotarget; 2015 Dec; 6(42):44758-80. PubMed ID: 26556872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
